Liege, Belgium, 26 April 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA) today announces a collaboration with MedinCell for the development of two long-acting injectable products in its CDMO based in Liège. Mithra CDMO offers a complete spectrum of solutions from early drug development, clinical batches and commercial manufacturing of complex polymeric products (vaginal […]

Liege, Belgium, 20 April 2022 – 07:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that Goldman Sachs International (“GSI”) has elected to exercise a call option for an amount of EUR 5,000,000 on 19 April, 2022, according to the terms of the […]

Liege, Belgium, 19 April 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces the invitation to its ordinary and extraordinary securities holders’ meeting that will be held on Thursday May 19 2022 at 2:00 PM (CEST). The notice for the General Meeting including a description of the […]

Liege, Belgium, 18 April 2022 – 7:30 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (“Mithra” or the “Company”), a company dedicated to Women’s Health, today announces the extension of the capital commitment agreement with LDA Capital Limited (“LDA Capital“) for a period of two additional years, as well as the increase of the commitment […]

Liege, Belgium, 15 April 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces the publication of its 2021 Annual Report. The Annual Report which outlines Mithra’s achievements in 2021 includes the following information: – Overview of Mithra’s R&D pipeline and letter to shareholders; – Highlights of Mithra’s […]

• Consolidated analysis of Phase 3 topline data showed even more positive results than initially announced, with all four co-primary endpoints met • Donesta® safety profile confirmed by independent Data Safety Monitoring Board (DSMB), which recommended to continue the Phase III Clinical Program • Launch of the recruitment of the additional 300 menopausal women thanks […]

Liege, Belgium, 8 April 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]

Liege, Belgium, 29 March 2022 – 18:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]

Liege, Belgium, 29 March 2022 –17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]

Liege, Belgium, 23 March 2022 –17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]